Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sonoma Pharmaceuticals, Inc.

2.02
-0.0900-4.27%
Post-market: 2.020.00000.00%19:18 EDT
Volume:70.52K
Turnover:139.51K
Market Cap:3.26M
PE:-0.44
High:2.08
Open:2.05
Low:1.90
Close:2.11
Loading ...

Fast-paced Momentum Stock Sonoma Pharmaceuticals (SNOA) Is Still Trading at a Bargain

Zacks
·
27 Mar

Delaware passes law designed to stop more Elon Musks from leaving state

Yahoo Finance
·
27 Mar

Wall Street Stabilizes, Driving Quiet Premarket Action for US Equity Futures

MT Newswires Live
·
11 Mar

Why Fast-paced Mover Sonoma Pharmaceuticals (SNOA) Is a Great Choice for Value Investors

Zacks
·
11 Mar

Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)

ACCESS Newswire
·
11 Mar

Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando

ACCESS Newswire
·
26 Feb

More Musk-like 'Dexits' pose fresh threat to Delaware's corporation crown

Yahoo Finance
·
15 Feb

Sonoma Pharmaceuticals Third Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
07 Feb

Sonoma Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
07 Feb

Sonoma Pharmaceuticals Q3 2025 GAAP EPS $(0.63) Beats $(0.69) Estimate, Sales $3.564 Miss $4.060M Estimate

Benzinga
·
06 Feb

Sonoma Pharmaceuticals Inc expected to post a loss of 69 cents a share - Earnings Preview

Reuters
·
05 Feb

Sonoma transitions first products to new EU MDR requirements

TIPRANKS
·
05 Dec 2024

BRIEF-Sonoma Pharmaceuticals Terminates Supply And Distribution Agreement With EMC Pharma

Reuters
·
22 Nov 2024

Sonoma Pharmaceuticals Inc - to Resume Selling Acuicyn, Celacyn, Epicyn, Lasercyn, Levicyn in U.S.

THOMSON REUTERS
·
22 Nov 2024

Sonoma Pharmaceuticals Inc - Terminates Supply and Distribution Agreement With Emc Pharma

THOMSON REUTERS
·
22 Nov 2024

Sonoma Pharmaceuticals announces relaunch of dermatology, eye care lines

TIPRANKS
·
22 Nov 2024

Sonoma Pharmaceuticals Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
12 Nov 2024

Sonoma Pharmaceuticals Gets FDA Clearance for Hydrogel Wound Treatment

MT Newswires Live
·
12 Nov 2024

FDA grants Sonoma 510(k) approval for Microdacyn Hydrogel

TIPRANKS
·
11 Nov 2024

Sonoma Pharmaceuticals Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
09 Nov 2024